PRESS RELEASE published on 06/08/2026 at 22:35, 12 days 6 hours ago DBV Technologies présente de nouvelles données positives issues de l’étude de phase 3 VITESSE, et un aperçu de l’étude THRIVE récemment initiée à l’occasion du Congrès de l’EAACI 2026 DBV Technologies présente de nouvelles données positives de l'étude de phase 3 VITESSE sur le patch VIASKIN Peanut pour les allergies à l'arachide, avec un aperçu de l'étude THRIVE au congrès EAACI 2026 DBV Technologies Allergies Alimentaires Étude VITESSE Patch Viaskin Peanut Étude THRIVE
PRESS RELEASE published on 06/08/2026 at 22:35, 12 days 6 hours ago DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 DBV Technologies to present new positive data from VITESSE study and preview THRIVE study at EAACI Congress 2026. VIASKIN Peanut Patch efficacy in peanut-allergic children with atopic comorbidities DBV Technologies Viaskin Peanut Patch VITESSE Study THRIVE Study EAACI Congress 2026
BRIEF published on 06/08/2026 at 09:37, 12 days 19 hours ago DBV Technologies: JP Morgan Chase & Co. falls below the 10% threshold Share Capital Voting Rights Threshold Crossing DBV Technologies JP Morgan Chase
BRIEF published on 06/08/2026 at 09:37, 12 days 19 hours ago DBV Technologies : J.P. Morgan Chase & Co. franchit à la baisse le seuil de 10% Droits De Vote Franchissement De Seuil DBV Technologies Capital Actions J.P. Morgan Chase
PRESS RELEASE published on 06/08/2026 at 09:32, 12 days 19 hours ago Franchissement de seuils Déclaration de franchissement de seuils par J.P. Morgan Chase & Co. pour DBV Technologies. Baisse à 8,68% du capital et des droits de vote Capital Droits De Vote Franchissement De Seuils DBV Technologies J.P. Morgan Chase & Co.
BRIEF published on 06/05/2026 at 22:35, 15 days 6 hours ago DBV Technologies presents at the Goldman Sachs Global Healthcare Conference Immunotherapy DBV Technologies Viaskin Food Allergies Goldman Sachs Conference
BRIEF published on 06/05/2026 at 22:35, 15 days 6 hours ago DBV Technologies to Present at Goldman Sachs Healthcare Conference DBV Technologies Food Allergies Epicutaneous Immunotherapy VIASKIN Patch Goldman Sachs Healthcare Conference
BRIEF published on 06/05/2026 at 22:35, 15 days 6 hours ago DBV Technologies présentera ses services lors de la conférence Goldman Sachs sur les soins de santé. Allergies Alimentaires Immunothérapie Épicutanée Technologies DBV Patch VIASKIN Conférence Goldman Sachs Sur Les Soins De Santé
BRIEF published on 06/05/2026 at 22:35, 15 days 6 hours ago DBV Technologies présente à la conférence Global Healthcare de Goldman Sachs Immunothérapie DBV Technologies Allergies Alimentaires Viaskin Conférence Goldman Sachs
PRESS RELEASE published on 06/05/2026 at 22:30, 15 days 6 hours ago DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference DBV Technologies to participate in Goldman Sachs 47th Annual Global Healthcare Conference. Developing treatment options for food allergies with VIASKIN patch technology Clinical Trials DBV Technologies Food Allergies Goldman Sachs Conference VIASKIN Patch Technology
Published on 06/20/2026 at 01:00, 1 day 3 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 4 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 3 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 3 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 7 hours 14 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 22 hours 40 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 8 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 8 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 9 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 9 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 9 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026